Provided by Tiger Trade Technology Pte. Ltd.

Onconetix Inc.

0.6634
+0.01822.82%
Post-market: 0.67580.0124+1.88%19:58 EDT
Volume:129.35K
Turnover:85.90K
Market Cap:2.62M
PE:-0.25
High:0.6900
Open:0.6390
Low:0.6390
Close:0.6452
52wk High:209.50
52wk Low:0.5859
Shares:3.95M
Float Shares:3.69M
Volume Ratio:0.37
T/O Rate:3.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6880
EPS(LYR):-828.1488
ROE:-105.23%
ROA:-27.03%
PB:0.19
PE(LYR):0.00

Loading ...

Oncopeptides Targets Third-Line Multiple Myeloma Indication to Boost Pepaxti Growth

TIPRANKS
·
May 11

Oncopeptides Sets May 13 Webcast for Q1 2026 Results

TIPRANKS
·
May 06

Onconetix files to sell 25M shares of common stock for holders

TIPRANKS
·
Apr 29

Oncopeptides Marks Growth Phase as 2025 Annual Report Highlights Pepaxti Momentum

TIPRANKS
·
Apr 29

BRIEF-Onconetix Inc Andrew Oakley Resigns As Chairman Of Board

Reuters
·
Apr 25

Onconetix Inc - Appoints Sammy Dorf as Chairman of the Board Effective April 23, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 25

HRT Financial disposes of Onconetix common shares worth $111,832

Reuters
·
Apr 22

HRT Financial acquires $126,694 of Onconetix common shares

Reuters
·
Apr 17

Onconetix files Form 3 as HRT Financial LP reports beneficial ownership

Reuters
·
Apr 17

Onconetix says Realbotix acquisition expected to close in second half of 2026

Reuters
·
Apr 09

Onconetix says Realbotix expects delivery of 19 robots as acquisition pending

Reuters
·
Apr 02

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

THOMSON REUTERS
·
Apr 02

Onconetix names David White CEO as it pursues Realbotix acquisition

Reuters
·
Apr 01

BRIEF-Onconetix Appoints David White As Chief Executive Officer And Sammy Dorf As Member Of The Board Of Directors

Reuters
·
Mar 31

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

THOMSON REUTERS
·
Mar 31

Onconetix Inc - Karina Fedasz to Continue as Interim CFO at Onconetix

THOMSON REUTERS
·
Mar 31

Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push

TIPRANKS
·
Mar 31

Onconetix files initial beneficial ownership statement; CEO David Allan White reports no securities beneficially owned

Reuters
·
Mar 28

Onconetix files Form 3 initial beneficial ownership statement; director Sammy Dorf reports no securities beneficially owned

Reuters
·
Mar 28

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:16 AM

Reuters
·
Mar 27